Medical tech firm Becton Dickinson reaffirms commitment to advancing patient safety

The company's solutions cover a wide range of medical devices and technologies

Last updated:
1 MIN READ
Patient safety and all the associated elements get to be highlighted on one day of the year. But for all stakeholders in the healthcare industry, the focus is constant.
Patient safety and all the associated elements get to be highlighted on one day of the year. But for all stakeholders in the healthcare industry, the focus is constant.
Supplied

Dubai: On World Patient Safety Day, the Dubai branch of NYSE-listed Becton, Dickinson and Company (BD) has reaffirmed its commitment to advancing patient safety.

Observed on September 17, BD said it is uniting with the global healthcare community in championing patient safety, emphasizing the role of healthcare professionals and medical technology companies, in addition to patients and their families, in ensuring unwavering patient care and safety.

"Patient safety is a core value that knows no boundaries, especially in the MENAT region," said Maher Elhassan, Vice President and General Manager of BD MENAT. "Our goal is to raise safety standards, decrease the risks associated with medical errors, and bolster the ongoing resilience of healthcare," he added.

Early last month, BD announced the enrollment of the first patient in the investigational device exemption (IDE) study, "Arch."

The study is a global, prospective, multi-centre, single-arm clinical study for treating complications from portal hypertension, assessing the safety and effectiveness of the investigational BD Liverty TIPS Stent Graft.

The ARCH Study will include 175 patients at up to 40 clinical study sites across the United States and Europe.

Sign up for the Daily Briefing

Get the latest news and updates straight to your inbox

Up Next